Technical Analysis for IQV - IQVIA Holdings, Inc.

Grade Last Price % Change Price Change
B 253.87 0.46% 1.16
IQV closed up 0.46 percent on Monday, March 18, 2024, on 70 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
5 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
NR7 Range Contraction 0.46%
Down 3 Days in a Row Weakness 0.46%
Gapped Down Weakness 0.46%
MACD Bearish Signal Line Cross Bearish -0.15%
Overbought Stochastic Strength -0.15%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 10 hours ago
Possible Inside Day about 10 hours ago
Possible NR7 3 days ago
Reversed from Down 4 days ago
1.5x Volume Pace 4 days ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

IQVIA Holdings, Inc. Description

IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services. The Research & Development Solutions segment provides biopharmaceutical development services. It offers project management and clinical monitoring, clinical trial support services, Q2 solutions, and strategic planning and design. The Integrated Engagement Services segment offerings include healthcare provider engagement services, patient engagement services, and scientific strategy and medical affairs services. The Company has its operations in the Americas, Europe and Africa, and the Asia-Pacific.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: S&P 500 Life Sciences Technology Solutions Project Management Healthcare Service Biopharmaceutical Development Q2 Technology Enabled Healthcare Services

Is IQV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 261.73
52 Week Low 167.42
Average Volume 1,046,578
200-Day Moving Average 216.47
50-Day Moving Average 231.09
20-Day Moving Average 250.89
10-Day Moving Average 255.33
Average True Range 5.39
RSI (14) 62.41
ADX 31.94
+DI 29.97
-DI 19.37
Chandelier Exit (Long, 3 ATRs) 245.57
Chandelier Exit (Short, 3 ATRs) 246.87
Upper Bollinger Bands 263.39
Lower Bollinger Band 238.38
Percent B (%b) 0.62
BandWidth 9.97
MACD Line 7.08
MACD Signal Line 8.09
MACD Histogram -1.0094
Fundamentals Value
Market Cap 46.33 Billion
Num Shares 183 Million
EPS 5.96
Price-to-Earnings (P/E) Ratio 42.60
Price-to-Sales 2.68
Price-to-Book 6.86
PEG Ratio 1.89
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 258.06
Resistance 3 (R3) 257.95 256.46 257.36
Resistance 2 (R2) 256.46 255.39 256.51 257.12
Resistance 1 (R1) 255.16 254.73 254.42 255.27 256.89
Pivot Point 253.67 253.67 253.29 253.72 253.67
Support 1 (S1) 252.37 252.60 251.63 252.48 250.85
Support 2 (S2) 250.88 251.94 250.93 250.62
Support 3 (S3) 249.58 250.88 250.38
Support 4 (S4) 249.69